학술논문
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Document Type
Article
Author
Zabalza, A.; Arrambide, G.; Pappolla, A.; Tagliani, P.; López-Maza, S.; Cárdenas-Robledo, S.; Castillo, M.; Bonastre, M.; Resina-Salles, M.; Bertran, J.; Rodriguez-Barranco, M.; Carbonell-Mirabent, P.; Rodríguez-Acevedo, B.; Midaglia, L.; Vidal-Jordana, Á.; Cobo-Calvo, Á.; Tur, C.; Galan, I.; Castillo, J.; Río, J.; Espejo, C.; Comabella, M.; Nos, C.; Sastre-Garriga, J.; Tintoré, M.; Montalban, X.; Otero-Romero, S.; Esperalba, J.; Fernández-Naval, C.; Martínez-Gallo, M.; Gonzalez, M.; Merchan, M.; Álvarez, G.; Quiroga-Varela, A.; Miguela, A.; Gómez, I.; Robles, R.; Ramió-Torrentà, L.; Perez del Campo, D.; Queralt, X.; Soler, M.J.; Agraz, I.; Martinez-Valle, F.
Source
In: Multiple Sclerosis Journal . (Multiple Sclerosis Journal, June 2022, 28(7):1138-1145)
Subject
Language
English
ISSN
14770970
13524585
13524585